U.K. Healthcare Top Stock Picks from Analysts

Integrated Diagnostics Holdings

Market Cap: US$251.1m

Operates as a consumer healthcare company that provides medical diagnostics services to patients.

AOTI

Market Cap: UK£68.7m

Produces, rents, and sells medical devices to resolve severe acute and chronic wounds for customers worldwide.

Kooth

Market Cap: UK£56.8m

Provides digital mental health services to children, young people, and adults in the United Kingdom.

Creo Medical Group

Market Cap: UK£55.3m

Through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments for clinics and hospitals in the United Kingdom.

ANGLE

Market Cap: UK£19.3m

A medical diagnostic company, engages in developing cancer diagnostics products in the United Kingdom, Europe, North America, and internationally.

EMV Capital

Market Cap: UK£12.8m

A venture capital firm specializing in seed, growth capital, early and mid stage investments.

Polarean Imaging

Market Cap: UK£11.2m

Operates as a drug-device manufacturer and service provider for noble gas hyperpolariser devices in Canada, the United Kingdom, and the United States.

Cambridge Cognition Holdings

Market Cap: UK£10.9m

Develops and markets digital solutions for the assessment of brain health in the United States, United Kingdom, the European Union, and internationally.

Cambridge Nutritional Sciences

Market Cap: UK£7.7m

Develops, manufactures, and distributes medical diagnostics products for the food sensitivity testing market.

RUA Life Sciences

Market Cap: UK£7.5m

Engages in the provision of polymers, services, and products to the medical device industry in Europe, the United States, and internationally.

Surgical Innovations Group

Market Cap: UK£6.5m

Engages in the design, manufacture, and export of medical products for use in laparoscopic and robotic minimally invasive surgery in the United Kingdom, Europe, the Asia Pacific, the United States, and internationally.

Feedback

Market Cap: UK£5.8m

Provides software and systems to those working in the field of medical imaging.

GENinCode

Market Cap: UK£4.0m

Develops and commercializes clinical genetic tests to provide predictive analysis of risk to a patient’s health based on their genes in the United Kingdom and internationally.